Medicare Enrolled

Dr. David Hatcher, M.D.

Surgery · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1441 EASTLLAKE AVE, Los Angeles, CA 90089
3238653700
In practice since 2011 (15 years)
NPI: 1417256488 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hatcher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatcher? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hatcher

Dr. David Hatcher is a surgery specialist in Los Angeles, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Hatcher performed 633 Medicare services across 406 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hatcher received a total of $10,360 from 15 pharmaceutical and/or device companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hatcher is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 15% volume in CA $10,360 industry payments

Medicare Practice Summary

Medicare Utilization ↗
633
Medicare services
Top 15% in CA for surgery
406
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Leuprolide acetate (for depot suspension), 7.5 mg 132 $129 $1,982
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
88 $8 $115
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
72 $201 $772
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
69 $43 $149
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
67 $70 $247
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $32 $148
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
35 $44 $238
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
33 $27 $173
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
19 $49 $240
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $110 $343
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
15 $198 $850
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
15 $123 $510
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $96 $344
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,360
Total received (2018-2024)
Avg $1,727/year across 6 years
Top 23% in CA for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
31
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,511 (82.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,849 (17.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,586
2023
$1,033
2022
$345
2021
$6,275
2019
$109
2018
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,257
Teleflex LLC
$116
COLOPLAST CORP
$70
Astellas Pharma US Inc
$31
ABBVIE INC.
$28
IMMUNITYBIO, INC.
$27
Ferring Pharmaceuticals Inc.
$23
Photocure Inc
$18
UROGEN PHARMA, INC.
$17
Top 3 companies account for 94.5% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$7,287
INTUITIVE SURGICAL, INC.
$2,257
Teleflex LLC
$412
Retrophin, Inc.
$109
COLOPLAST CORP
$70
Astellas Pharma US Inc
$31
PROCEPT BioRobotics Corporation
$30
ABBVIE INC.
$28
IMMUNITYBIO, INC.
$27
Ferring Pharmaceuticals Inc.
$23
BOSTON SCIENTIFIC CORPORATION
$21
Photocure Inc
$18
UROVANT SCIENCES INC
$18
UROGEN PHARMA, INC.
$17
Boston Scientific Corporation
$12
Top 3 companies account for 96.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · BOTOX · CYSVIEW · DA VINCI SP · Da Vinci Surgical System · GEMTESA · GENERAL BPH · JELMYTO · REZUM · Restorelle · UROLIFT · UroLift System · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgery and does not inherently indicate bias, but patients may wish to be aware.

Looking for a surgery specialist in Los Angeles?
Compare surgerists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse surgerists nearby

Geographic Context

Surgerists within 10 mi
822
Per 100K population
8.3
County median income
$87,760
Nearest hospital
CALIFORNIA HOSPITAL MEDICAL CENTER LA
1.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hatcher is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with speaking/promotional industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hatcher experienced with leuprolide acetate (for depot suspension), 7.5 mg?
Based on Medicare claims data, Dr. Hatcher performed 132 leuprolide acetate (for depot suspension), 7.5 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hatcher receive payments from pharmaceutical companies?
Yes. Dr. Hatcher received a total of $10,360 from 15 companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hatcher's costs compare to other surgerists in Los Angeles?
Dr. Hatcher's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hatcher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →